Literature DB >> 8409379

Clonal deletion of V beta 5+ T cells by transgenic I-E restricted to thymic medullary epithelium.

L C Burkly1, S Degermann, J Longley, J Hagman, R L Brinster, D Lo, R A Flavell.   

Abstract

A variety of cell types expressing MHC class II molecules is known to function as APC in vitro. We employed the Ig kappa gene enhancer and promoter to target the class II E alpha gene, and thereby I-E, exclusively to B cells to address their APC function in vivo. Although transgenic I-E was expressed on B lymphocytes, we unexpectedly obtained I-E on thymic medullary epithelium but not macrophages and at low frequency on dendritic cells. Using these transgenic mice, we constructed bone marrow irradiation chimeras with I-E expressed only on medullary epithelium, in order to determine the role of this cell type in tolerance by clonal deletion in the thymus. Although it is accepted that bm-derived cells play a primary role in deletion, and thymic epithelium can delete clones to a lesser degree, the role of cortical vs medullary thymic epithelium has not been directly dissected. We demonstrate that medullary epithelium alone can tolerize by partial deletion of I-E-reactive V beta 5+ T cells. These results indicate a role for medullary epithelium in deletion during the later stages of thymic development, and support the notion that positive and negative selection of developing T cells can occur in distinct temporal and anatomic compartments.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409379

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Immune regulation: susceptibility and resistance to autoimmunity.

Authors:  D Lo
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity.

Authors:  Rongfang Wang; Yiran Wang-Zhu; Howard Grey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

3.  NF-kappaB2 is required for the control of autoimmunity by regulating the development of medullary thymic epithelial cells.

Authors:  Baochun Zhang; Zhe Wang; Jane Ding; Pärt Peterson; William T Gunning; Han-Fei Ding
Journal:  J Biol Chem       Date:  2006-10-17       Impact factor: 5.157

4.  Costimulatory signals are required for induction of transcription factor Nur77 during negative selection of CD4(+)CD8(+) thymocytes.

Authors:  D Amsen; C Revilla Calvo; B A Osborne; A M Kruisbeek
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 5.  Thymic stromal cell specialization and the T-cell receptor repertoire.

Authors:  D Lo; C R Reilly; L C Burkly; J DeKoning; T M Laufer; L H Glimcher
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

6.  Two levels of help for B cell alloantibody production.

Authors:  D J Steele; T M Laufer; S T Smiley; Y Ando; M J Grusby; L H Glimcher; H Auchincloss
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

7.  Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo.

Authors:  T Brocker; M Riedinger; K Karjalainen
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

8.  Deletion of high-avidity T cells by thymic epithelium.

Authors:  M W Hoffmann; W R Heath; D Ruschmeyer; J F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

9.  Quantitative impact of thymic clonal deletion on the T cell repertoire.

Authors:  J P van Meerwijk; S Marguerat; R K Lees; R N Germain; B J Fowlkes; H R MacDonald
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

10.  A T cell receptor-specific blockade of positive selection.

Authors:  K K Baldwin; P A Reay; L Wu; A Farr; M M Davis
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.